Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies
Yannick Le Bris(Centre National de la Recherche Scientifique), Marie C. Béné(Centre Hospitalier Universitaire de Nantes), Domitille Costes, Patrice Chevallier(Hotel Dieu Hospital), Alice Garnier, Amandine Le Bourgeois, Thierry Guillaume(Centre National de la Recherche Scientifique), Raphaël Bourgade(Inserm), Pierre Péterlin(Hotel Dieu Hospital)
Cited by 5
Related Papers
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
|Blood|2013|357
Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration*
|Critical Care Medicine|2014|109